Terms: = Bone cancer AND BLM, MGC131620, 641, ENSG00000197299, MGC131618, RECQ2, RECQL2, RECQL3, MGC126616, BS AND Staging
86 results:
1. Head-to-head Comparison of the Diagnostic Accuracy of Prostate-specific Membrane Antigen Positron Emission Tomography and Conventional Imaging Modalities for Initial staging of Intermediate- to High-risk Prostate cancer: A Systematic Review and Meta-analysis.
Chow KM; So WZ; Lee HJ; Lee A; Yap DWT; Takwoingi Y; Tay KJ; Tuan J; Thang SP; Lam W; Yuen J; Lawrentschuk N; Hofman MS; Murphy DG; Chen K
Eur Urol; 2023 Jul; 84(1):36-48. PubMed ID: 37032189
[TBL] [Abstract] [Full Text] [Related]
2. bone Metastases Detection in Patients with Breast cancer: Does bone Scintigraphy Add Information to PET/CT?
Cristo Santos J; Henriques Abreu M; Seoane Santos M; Duarte H; Alpoim T; Próspero I; Sousa S; Henriques Abreu P
Oncologist; 2023 Aug; 28(8):e600-e605. PubMed ID: 37029988
[TBL] [Abstract] [Full Text] [Related]
3. Impact of Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography on the Therapeutic Decision of Prostate Carcinoma Primary staging: A Retrospective Analysis at the Brazilian National Public Health System.
da Silva ACB; de Toledo LGM; de Carvalho Fernandes R; Ziroldo AR; Sawczyn GV; Alarcon ST; Lewin F
Ann Surg Oncol; 2023 Jul; 30(7):4541-4549. PubMed ID: 36995451
[TBL] [Abstract] [Full Text] [Related]
4. A prospective, multicenter head-to-head comparative study in patients with primary high-risk prostate cancer investigating the bone lesion detection of conventional imaging and
Bodar YJL; Luining WI; Keizer B; Meijer D; Vellekoop A; Schaaf M; Hendrikse NH; Van Moorselaar RJA; Oprea-Lager DE; Vis AN
Urol Oncol; 2023 Apr; 41(4):205.e17-205.e24. PubMed ID: 36588019
[TBL] [Abstract] [Full Text] [Related]
5. Role of
Sopeña Sutil R; Gómez Grande A; González Díaz A; Téigel Tobar J; Cabeza Rodríguez MÁ; González Billalabeitia E; Rodríguez Antolín A
Arch Esp Urol; 2022 Oct; 75(8):684-692. PubMed ID: 36330569
[TBL] [Abstract] [Full Text] [Related]
6. The value of 68 Ga-PSMA-11 PET/CT in patients with prostate cancer and inconclusive standard imaging at primary staging.
Nalliah S; Zacho HD
Nucl Med Commun; 2022 Oct; 43(10):1092-1098. PubMed ID: 35950348
[TBL] [Abstract] [Full Text] [Related]
7. A Web-Based Prediction Model for Overall Survival of Elderly Patients With Malignant bone Tumors: A Population-Based Study.
Tang J; Wang J; Pan X
Front Public Health; 2021; 9():812395. PubMed ID: 35087789
[No Abstract] [Full Text] [Related]
8. The role of MRI in the management of a prostate cancer patient with bone and lymph nodes metastases. A case report.
Belmonte M; Saia G; Zugni F; Alessi S; Colombo A; Summers PE; Luzzago S; Marvaso G; Musi G; De Cobelli O; Jereczek-Fossa BA; Petralia G
Acta Biomed; 2021 Sep; 92(4):e2021214. PubMed ID: 34487080
[TBL] [Abstract] [Full Text] [Related]
9. Outcomes of Burkitt lymphoma with central nervous system involvement: evidence from a large multicenter cohort study.
Zayac AS; Evens AM; Danilov A; Smith SD; Jagadeesh D; Leslie LA; Wei C; Kim SH; Naik S; Sundaram S; Reddy N; Farooq U; Kenkre VP; Epperla N; Blum KA; Khan N; Singh D; Alderuccio JP; Godara A; Yazdy MS; Diefenbach C; Rabinovich E; Varma G; Karmali R; Shao Y; Trabolsi A; Burkart M; Martin P; Stettner S; Chauhan A; Choi YK; Straker-Edwards A; Klein A; Churnetski MC; Boughan KM; Berg S; Haverkos BM; Orellana-Noia VM; D'Angelo C; Bond DA; Maliske SM; Vaca R; Magarelli G; Sperling A; Gordon MJ; David KA; Savani M; Caimi P; Kamdar M; Lunning MA; Palmisiano N; Venugopal P; Portell CA; Bachanova V; Phillips T; Lossos IS; Olszewski AJ
Haematologica; 2021 Jul; 106(7):1932-1942. PubMed ID: 33538152
[TBL] [Abstract] [Full Text] [Related]
10. Application of Diffusion Weighted Imaging in Prostate cancer bone Metastasis: Detection and Therapy Evaluation.
Gong XQ; Tao YY; Wang R; Liu N; Huang XH; Zheng J; Yang C; Yang L; Zhang XM
Anticancer Agents Med Chem; 2021; 21(15):1950-1956. PubMed ID: 33461473
[TBL] [Abstract] [Full Text] [Related]
11. Whole-body magnetic resonance imaging for prostate cancer assessment: Current status and future directions.
Van Nieuwenhove S; Van Damme J; Padhani AR; Vandecaveye V; Tombal B; Wuts J; Pasoglou V; Lecouvet FE
J Magn Reson Imaging; 2022 Mar; 55(3):653-680. PubMed ID: 33382151
[TBL] [Abstract] [Full Text] [Related]
12. Looking for Metastasis in Early Breast cancer: Does bone Scan Help? A Retrospective Review.
James J; Teo M; Ramachandran V; Law M; Ip E; Cheng M
Clin Breast Cancer; 2021 Feb; 21(1):e18-e21. PubMed ID: 32950408
[TBL] [Abstract] [Full Text] [Related]
13. Clinical impact of PSMA PET/CT in primary prostate cancer compared to conventional nodal and distant staging: a retrospective single center study.
Donswijk ML; van Leeuwen PJ; Vegt E; Cheung Z; Heijmink SWTPJ; van der Poel HG; Stokkel MPM
BMC Cancer; 2020 Aug; 20(1):723. PubMed ID: 32758168
[TBL] [Abstract] [Full Text] [Related]
14. A Prospective Comparison of
Anttinen M; Ettala O; Malaspina S; Jambor I; Sandell M; Kajander S; Rinta-Kiikka I; Schildt J; Saukko E; Rautio P; Timonen KL; Matikainen T; Noponen T; Saunavaara J; Löyttyniemi E; Taimen P; Kemppainen J; Dean PB; Blanco Sequeiros R; Aronen HJ; Seppänen M; Boström PJ
Eur Urol Oncol; 2021 Aug; 4(4):635-644. PubMed ID: 32675047
[TBL] [Abstract] [Full Text] [Related]
15. Unwarranted imaging for distant metastases in patients with newly diagnosed ductal carcinoma in situ and stage I and II breast cancer.
Lupichuk S; Tilley D; Surgeoner B; King K; Joy AA
Can J Surg; 2020 Feb; 63(2):E100-E109. PubMed ID: 32109016
[TBL] [Abstract] [Full Text] [Related]
16. Do patients who undergo multiparametric MRI for prostate cancer benefit from additional staging imaging? Results from a statewide collaborative.
Eyrich NW; Tosoian JJ; Drobish J; Montie JE; Qi J; Kim T; Noyes SL; Moriarity AK; Lane BR;
Urol Oncol; 2020 Jul; 38(7):636.e13-636.e19. PubMed ID: 32067844
[TBL] [Abstract] [Full Text] [Related]
17. Whole-body MRI: a powerful alternative to bone scan for bone marrow staging without radiation and gadolinium enhancer.
Papageorgiou I; Dvorak J; Cosma I; Pfeil A; Teichgraeber U; Malich A
Clin Transl Oncol; 2020 Aug; 22(8):1321-1328. PubMed ID: 31858434
[TBL] [Abstract] [Full Text] [Related]
18. Transitioning to whole-body SPECT/CT in prostate cancer staging: a new concept for a better imaging workflow.
Weissinger M; Kupferschläger J; La Fougère C; Dittmann H; Fiz F
Nuklearmedizin; 2019 Dec; 58(6):451-459. PubMed ID: 31711243
[TBL] [Abstract] [Full Text] [Related]
19. A Review of Prostate-Specific Membrane Antigen (PSMA) Positron Emission Tomography (PET) in Renal Cell Carcinoma (RCC).
Ahn T; Roberts MJ; Abduljabar A; Joshi A; Perera M; Rhee H; Wood S; Vela I
Mol Imaging Biol; 2019 Oct; 21(5):799-807. PubMed ID: 30617728
[TBL] [Abstract] [Full Text] [Related]
20. Multiparametric whole-body 3.0-T MRI in newly diagnosed intermediate- and high-risk prostate cancer: diagnostic accuracy and interobserver agreement for nodal and metastatic staging.
Johnston EW; Latifoltojar A; Sidhu HS; Ramachandran N; Sokolska M; Bainbridge A; Moore C; Ahmed HU; Punwani S
Eur Radiol; 2019 Jun; 29(6):3159-3169. PubMed ID: 30519933
[TBL] [Abstract] [Full Text] [Related]
[Next]
